G.P. Nicolella - Concepedia

Author

G.P. Nicolella

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Also Known As

G Nicolella, G. Nicolella, G.P Nicolella, G.P. Nicolella, Gianpaolo Nicolella, Gianpaolo P. Nicolella

Publications

Citations

H-Index

Concepts

All Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Fatebenefratelli Hospital Tumour Institute of Tuscany

About

G.P. Nicolella is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in oncology, cancer therapeutics, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	192
2	Health Sciences	2	2	26
3	Pharmacology	2	2	97
4	Obstetrics	1	1	39
5	Pathology	1	1	30

G.P. Nicolella

Publications

989

Citations

H-Index

Page 1

	Year	Citations
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer G. Frasci, Vito Lorusso, Nicola Panza, Journal of Clinical Oncology	2000	452
Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group Pasquale Comella, G. Frasci, Nicola Panza, Journal of Clinical Oncology	2000	177
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial G. Frasci, Vito Lorusso, Nicola Panza, Lung Cancer OncologyElderly PatientsMedicinePhase Iii TrialClinical Trials	2001	86
Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group Pasquale Comella, G. Frasci, Nicola Panza, Journal of Clinical Oncology	1999	73
Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II Study G. Frasci, Nicola Panza, Pasquale Comella, Journal of Clinical Oncology	1999	54
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study G. Frasci, N. Panza, P. Comella, Annals of Oncology G-csf SupportDose-finding StudyMedicineCancer ManagementGynecology	1999	39
Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study G. Frasci, N. Panza, P. Comella, Annals of Oncology MedicinePathologyBronchial NeoplasmCancer TreatmentOncology	1997	30
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study G. Frasci, G.P. Nicolella, P. Comella, British Journal of Cancer	2001	28
Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial P. Comella, G. Frasci, N. Panza, Lung Cancer MedicineMetronomic TherapyPhase Iii TrialBronchial NeoplasmFirst-stage Analysis	2000	16
Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer. Gerardo Rosati, Antônio Rossi, G.P. Nicolella, PubMed	2000	13

Page 1